BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation

Journal of Urology

Volumn 163, Issue 6, 2000, Pages 2014-2021

  Pavlovich, Christian P ^b   Kräling, Birgit M ^b   Stewart, Robert J ^b   Chen, Xiaohong ^b   Bochner, Bernard H ^b   Luster, Andrew D ^b   Poppas, Dix P ^b   O'Donnell, Michael A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Angiogenesis; BCG; Endothelial cells; IP 10; TNF ; Urinary cytokines

Indexed keywords

BCG VACCINE;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE RELEASE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY CELL; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0342369545     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67620-3     Document Type: Article

References (55)

1. Huben, R. P.: Intravesical chemotherapy versus immunotherapy for superficial bladder cancer. Semin Urol Oncol (Suppl 1), 14: 17, 1996
2. De Jager, R., Guinan, P., Lamm, D., Khanna, O., Brosman, S., De Kernion, J., Williams, R., Richardson, B. A., Muenz, L., Reitsma, D. and Hanna, M. C. Jr.: Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette-Guerin: Overview analysis of six phase II clinical trials. Urology, 38: 507, 1991
3. Grossman, H. B.: Superficial bladder cancer: decreasing the risk of recurrence. Oncology, 10: 1617, 1996
4. Peuchmaur, M., Benoit, G., Viellefond, A., Chevalier, A., Lemaigre, G., Martin, E. D. and Jardin, A.: Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-Guerin. Urol Res, 17: 299, 1989
5. Prescott, S., James, K., Hargreave, T. B., Chisholm, G. D. and Smyth, J. F.: Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol, 147: 1636, 1992
6. Böhle, A., Nowc, Ch., Ulmer, A. J., Musehold, J., Gerdes, J., Hofstetter, A. G. and Flad, H-D.: Elevations of cytokines interleukin-1, interleukin-2, and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guérin immunotherapy. J Urol, 144: 59, 1990
7. Patard, J-J., Muscatelli-Groux, B., Saint, F., Popov, Z., Maille, P., Abbou, C. and Chopin, D.: Evaluation of local immune response after intravesical bacille Calmette-Guerin treatment for superficial bladder cancer. Br J Urol, 78: 709, 1996
8. Poppas, D. P., Pavlovich, C. P., Folkman, J., Voest, E. E., Chen, X., Luster, A. D. and O'Donnell, M. A.: Intravesical BCG induces the anti-angiogenic chemokine IP-10. Urology, 52: 268, 1998
9. Sato, N., Nariuchi, H., Tsuruoka, N., Nishihara, T., Beitz, J. G., Calabresi, P. and Frackleton, A. R. Jr.: Actions of TNF and IFN-γ on angiogenesis in vitro. J Invest Dermatol, 95: 85S, 1990
10. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. F., Maheshwari, S., Kleinman, H. K., Reaman, G. H. and Tosato, G.: Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med, 182: 155, 1995
11. Wanebo, H.: Tumor necrosis factors. Semin Surg Oncol, 5: 402-413, 1989
12. Nelson, B. and Borden, E.: Interferons: biological and clinical effects. Semin Surg Oncol, 5: 391, 1989
13. Luster, A. D. and Leder, P.: IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med, 178: 1057, 1993
14. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannetonni, M. D., Whyte, R. I. and Stricter, R. M.: Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med, 184: 981, 1996
15. Luster, A. D., Unkeless, J. C. and Ravetch, J. V.: Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature, 315: 672, 1985
16. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. and Folkman, J.: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst, 86: 356, 1994
17. Weingärtner, K., Ben-Sasson, S. A., Stewart, R., Richie, J. P., Riedmiller, H. and Folkman, J.: Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment. J Urol, 159: 465, 1998
18. Crew, J. P., O'Brien, T., Bradburn, M., Fuggle, S., Bicknell, R., Cranston, D. and Harris, A. L.: Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res, 57: 5281, 1997
19. Thalmann, G. N., Dewald, B., Baggiolini, M. and Studer, U. E.: Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression. J Urol, 158: 1340, 1997
20. Rabinowitz, R., Smith, D. S., Tiemann, D. D. and Hudson, M. A.: Urinary interleukin-8/creatinine level as predictor of response to intravesical bacillus Calmette-Guerin therapy in bladder tumor patients. J Urol, 158: 1728, 1997
21. Campbell, S. C.: Advances in angiogenesis research: relevance to urological oncology. J Urol, 158: 1663, 1997
22. Folkmanm J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1: 27, 1995
23. Luster, A. D., Greenberg, S. and Leder, P.: The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med, 182: 219, 1995
24. Kräling, B. M. and Bischoff, J.: A simplified method for growth of human microvascular endothelial cells results in decreases in senescence and continued responsiveness to cytokines and growth factors. In Vitro Cell Dev Biol, 33: 308, 1998
25. Folkman, J., Haundenschild, C. C. and Zetter, B. R.: Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA, 76: 5217, 1979
26. Oliver, M. H., Harrison, N. K., Bishop, J. E., Cole, P. J. and Laurent, G. J.: A rapid and convenient assay for counting cells cultured on microwell plates: Application for assessment of growth factors. J Cell Sci, 92: 513, 1989
27. Kundra, V., Anand-Apte, B., Feig, L. A. and Zetter, B. R.: The chemotactic response to PDGF-BB: evidence of a role for Ras. J Cell Biol, 130: 725, 1995
28. Boyden, S. J.: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med, 115: 453, 1962
29. Chodak, G. W., Hospelhorn, V., Judge, S. M., Mayforth, R., Koeppen, H. and Sasse, J.: Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res, 48: 2083, 1988
30. Chodak, G. W., Scheiner, C. J. and Zetter, B. R.: Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells. New Engl J Med, 305: 869, 1981
31. Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S. C., Skinner, D. G. and Nichols, P. W.: Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst, 87: 1603, 1995
32. Jaeger, T. M., Weidner, N., Chew, K., Moore, D. M., Kershmann, R. L., Waldman, F. M. and Carroll, P. R.: Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol, 154: 69, 1995
33. Dickinson, A. J., Fox, S. B., Persad, R. H., Hollyer, P. J, Sibley, G. N. and Harris, A. L.: Quantification of angiogenesis as an independent prognostic factor of prognosis in invasive bladder carcinoma. Br J Urol, 74: 762, 1994
34. de Reijke, T. M., deBoer, E. C., Kurth, K. H. and Schamhart, D. H. J.: Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability, and prognostic value. J Urol, 155: 477, 1996
35. Luster, A. D. and Ravetch, J. V.: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med, 166: 1084, 1987
36. Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J. and Oppenheim, J. J.: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med, 177: 1809, 1993
37. Sgadari, C., Angiolillo, A. L. and Tosato, G.: Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood, 87: 3877, 1996
38. Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, P., Clark-Lewis, I., Baggiolini, M. and Moser, B.: Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med, 184: 963, 1996
39. Garcia-Zepeda, E. A., Combadiere, C., Rothenberg, M. E., Sarafi, M. N., Lavigne, F., Hamid, Q., Murphy, P. M. and Luster, A. D.: Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol, 157: 5613, 1996
40. Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P. and Bohlen, P.: Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA, 84: 5277, 1987
41. Fajardo, L. F., Kwan, H. H., Kowalski, J., Prionas, S. D. and Allison, A. C.: Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol, 140: 539, 1992
42. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. and Folkman, J.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315, 1994
43. Ruszczak, Z., Detmar, M., Imcke, E. and Orfanos, C. E.: Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol, 95: 693, 1990
44. Jackson, A. M., Prescott, S., Hawkyard, S. J., James, J. and Chisholm, G.: The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical Evans BCG therapy. Cancer Immunol Immunother, 36: 25, 1993
45. Fujimoto, T., O'Donnell, M. A., Szilvasi, A., Yang, H. and Duda, R. B.: Bacillus Calmette-Guerin plus IL-2 and/or GM-CSF enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro. Cancer Immunol Immunother, 42: 280, 1996
46. Campbell, S. C., Volpert, O. V., Ivanovich, M. and Bouck, N. P.: Molecular mediators of angiogenesis in bladder cancer. Cancer Res, 58: 1298, 1998
47. Sidky, Y. A. and Borden, E. C.: Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res, 47: 5155, 1987
48. Belldegrun, A. S., Franklin, J. R., O'Donnell, M. A., Gomella, L. G., Klein, E., Neri, R., Nseyo, U. O., Ratliff, T. L. and Williams, R. D.: Superficial bladder cancer: The role of interferon-α. J Urol, 159: 1793, 1998
49. O'Donnell, M. A., Downs, T. M. and DeWolf, W. C.: Coadministration of interferon-alpha 2B with BCG is effective in patients with superficial bladder cancer previously failing BCG alone. J Immunother, 22: 463, 1999
50. Zhang, Y., Khoo, H. E. and Esuvaranathan, K.: Effects of bacillus Calmette-Guerin and Interferon alpha-2B on cytokine production in human bladder cancer cell lines. J Urol, 161: 977, 1999
51. Detma, M., Imcke, E., Ruszczak, Z. and Orfanos, C. E.: Effects of recombinant tumor necrosis factor-alpha on cultured microvascular endothelial cells derived from human dermis. J Invest Dermatol, 95: 219S, 1990
52. Hicks, C., Breit, S. N. and Penny, R.: Response of microvascular endothelial cells to biological response modifiers. Immunol Cell Biol, 67: 271, 1989
53. Pandita, R., Pocsik, E. and Aggarwal, B. B.: Interferon-gamma induces cell-surface expression for both types of tumor necrosis factor receptors. FEBS Lett, 312: 87, 1992
54. O'Donnell, M. A., Luo, Y., Chen, X., Szilvasi, A., Hunter, S. E. and Clinton, S. K.: Role of IL-12 in the induction and potentiation of IFN-γ in response to bacillus Calmette-Guerin (BCG). J Immunol, 163: 4246, 1999
55. Yoshida, A., Anand-apte, B. and Zetter, B. R.: Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors, 13: 57, 1996